Improving Tolerance of Treatment of Pulmonary MAC Infections
Status:
Withdrawn
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to improve tolerance of treatment of pulmonary Mycobacterium
avium Complex disease via the use of therapeutic drug monitoring and the addition of
anti-nausea medication or dietary supplements to the patients' daily drug regimen. The aims
of this study are to use (1) Zofran® (Ondansetron 8mg), an anti-nausea medication or (2) a
dietary supplement to decrease medication related gastrointestinal side effects of
medications used to treat Mycobacterium avium Complex.